- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Nonalcoholic Steatohapatitis
Total 725 results
-
Cairo UniversityActive, not recruitingNon-alcoholic SteatohepatitisEgypt
-
Genentech, Inc.TerminatedNon-alcoholic SteatohepatitisBelgium, United States, Spain, Puerto Rico, France
-
J2H BiotechCompletedNon-alcoholic SteatohepatitisKorea, Republic of
-
Novo Nordisk A/SCompleted
-
Enyo PharmaCompletedNon-alcoholic SteatohepatitisUnited States, Belgium, France, Puerto Rico, United Kingdom
-
Novo Nordisk A/SCompletedNon-alcoholic SteatohepatitisJapan
-
Madaus IncUniversity of Pennsylvania; Beth Israel Deaconess Medical Center; University... and other collaboratorsCompletedNon-alcoholic SteatohepatitisUnited States
-
Tehran University of Medical SciencesUnknownNon-alcoholic SteatohepatitisIran, Islamic Republic of
-
Madrigal Pharmaceuticals, Inc.UnknownNon-alcoholic SteatohepatitisUnited States
-
Mochida Pharmaceutical Company, Ltd.CompletedSteatohepatitisUnited States, Puerto Rico
-
University of California, San FranciscoUniversity of Colorado, Denver; The Methodist Hospital Research InstituteTerminatedEnd Stage Liver Disease | Chronic Kidney Diseases | Hepatitis B | Hepatocellular Carcinoma | Cirrhosis | Acute Kidney Injury | NASH - Nonalcoholic Steatohepatitis | Liver Transplant; Complications | Alcoholic Cirrhosis | Hepatitis cUnited States
-
Novartis PharmaceuticalsAllerganCompletedNon-alcoholic Steatohepatitis (NASH)United States, Belgium, Spain, Canada, Argentina, Israel, Germany, France, Italy, Turkey, Singapore, Russian Federation, United Kingdom, Czechia, Egypt, India, Latvia
-
University of Roma La SapienzaGöteborg UniversityCompletedObesity | Non-alcoholic Steatohepatitis (NASH) | Simple Steatosis (SS)Italy
-
Instituto de Investigación Marqués de ValdecillaUnknownNon-alcoholic Steatohepatitis (NASH)
-
Bambino Gesù Hospital and Research InstituteCompletedNAFLD | Non Alcoholic Steatohepatitis (NASH)Italy
-
Mitsubishi Tanabe Pharma CorporationCompleted
-
University of California, San DiegoCompletedNonalcoholic SteatohepatitisUnited States
-
AstraZenecaCompletedNon-Cirrhotic Non-alcoholic Steatohepatitis With FibrosisDenmark, Italy, Spain, United States, Argentina, Sweden, Mexico, Norway, Portugal
-
Merck Sharp & Dohme LLCRecruitingHepatic Impairment | Non-alcoholic SteatohepatitisUnited States
-
Novo Nordisk A/SCompletedNon-alcoholic Steatohepatitis | Hepatobiliary DisordersUnited States, Russian Federation, United Kingdom, Denmark, Sweden, Netherlands, Austria, Belgium, Spain, France, Bulgaria, Canada, Australia, Greece, Japan, Finland, Puerto Rico
-
University of BathAbertay UniversityCompletedNon-alcoholic Fatty Liver Disease | Non-alcoholic SteatohepatitisUnited Kingdom
-
Johane AllardCanadian Institutes of Health Research (CIHR); American College of GastroenterologyCompletedNon-alcoholic Fatty Liver Disease | Non-alcoholic SteatohepatitisCanada
-
GlaxoSmithKlineTerminatedLiver Diseases | HIV Infection | Thrombocytopenia | Hepatitis C Virus | HBV | NASH - Nonalcoholic Steatohepatitis | Human Immunodeficiency Virus | Chronic Liver Disease | HCV | Non-alcoholic Steatohepatitis | Hepatitis B VirusUnited States, Spain, Taiwan, Italy, Belgium, France, Korea, Republic of, Canada, Russian Federation, Pakistan, Poland, India, Argentina
-
Manal F AbdelmalekTerminatedNonalcoholic Fatty Liver Disease (NAFLD)United States
-
Fudan UniversityXinhua Hospital, Shanghai Jiao Tong University School of Medicine; Shanghai... and other collaboratorsRecruitingNon-alcoholic SteatohepatitisChina
-
J2H BiotechCompletedNon-alcoholic SteatohepatitisKorea, Republic of
-
AstraZenecaParexelCompletedNon-alcoholic SteatohepatitisUnited Kingdom
-
Milton S. Hershey Medical CenterNoom Inc.CompletedNon-alcoholic SteatohepatitisUnited States
-
Arrowhead PharmaceuticalsCompletedNon-alcoholic SteatohepatitisNew Zealand
-
University of North Carolina, Chapel HillNational Institute of General Medical Sciences (NIGMS)CompletedNon-alcoholic SteatohepatitisUnited States
-
University of VirginiaNational Center for Complementary and Integrative Health (NCCIH)CompletedFatty Liver | Non-alcoholic SteatohepatitisUnited States
-
Mayo ClinicCompletedObesity | Non-Alcoholic Steatohepatitis
-
Novartis PharmaceuticalsTerminatedNon Alcoholic Steatohepatitis (NASH)United States, South Africa, Spain, Germany, Italy, Taiwan, Canada, Korea, Republic of, Singapore, Bulgaria, Estonia, Mexico, Japan, Denmark, United Kingdom, Colombia, Brazil, Belgium, Russian Federation, Puerto Rico, Chile, Argen... and more
-
LISCure BiosciencesCompletedRheumatoid Arthritis | Non-Alcoholic SteatohepatitisAustralia
-
Galecto Biotech ABCovanceWithdrawn
-
Boehringer IngelheimRecruitingObesity | Non-Alcoholic SteatoHepatitis (NASH)United States
-
Corcept TherapeuticsCompletedNon-alcoholic Steatohepatitis (NASH) | Antipsychotic Induced Weight GainUnited States
-
Vanderbilt University Medical CenterTerminatedLiver Diseases | Liver Cirrhosis | NASH (Non-Alcoholic Steatohepatitis)United States
-
Association pour la Recherche sur les Maladies...CompletedNon Alcoholic SteatohepatitisFrance
-
Academisch Medisch Centrum - Universiteit van Amsterdam...RecruitingProbiotics | Non-Alcoholic Fatty Liver Disease | Microbiome | Gut Microbiome | Fecal Microbiota Transplantation | Intestinal Microbiome | FMT | Non Alcoholic Steatohepatitis | PrebioticsNetherlands
-
University of PalermoUnknownNon.Alcoholic Fatty Liver DiseaseItaly
-
Novo Nordisk A/SCompletedNon-alcoholic SteatohepatitisUnited States, Spain, France, United Kingdom, Germany
-
Institute of Liver and Biliary Sciences, IndiaCompletedNon-alcoholic SteatohepatitisIndia
-
Tanta UniversityActive, not recruitingNon-alcoholic SteatohepatitisEgypt
-
Gannex Pharma Co., Ltd.RecruitingNon-alcoholic Fatty Liver Disease | Non-alcoholic SteatohepatitisChina
-
AstraZenecaRecruitingNon-alcoholic Steatohepatitis (NASH)Austria, Germany, Japan, Sweden
-
Crolll GmbhUniversity of Magdeburg; Estimate, GmbHCompletedNon-alcoholic Steatohepatitis | Increased Iron Storage / Disturbed DistributionGermany
-
Chinese University of Hong KongNot yet recruitingNon-alcoholic Fatty Liver Disease (NAFLD) | Non-alcoholic Steatohepatitis (NASH)Hong Kong
-
Novartis PharmaceuticalsCompletedObese Patients With Non-alcoholic Steatohepatitis (NASH)Netherlands, Taiwan, Thailand, United States, Israel, Argentina, Russian Federation, Canada